Loading company
$2.39-0.6%Nov 13 close
Figures through December 31, 2025, from the 20-F filed March 27, 2026
Past performance
- 1W
- -3.8%
- 1M
- -38.5%
- 3M
- -80.4%
- 6M
- -91.2%
- 1Y
- -98.9%
- 5Y
- -100.0%
From the company’s own 6-K filing.
The quote and the company description come from the 6-K Biodexa Pharmaceuticals Plc filed on September 11, 2026 with its results; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
$2.39-0.6%Nov 13 close
Figures through December 31, 2025, from the 20-F filed March 27, 2026
Biodexa Pharmaceuticals Plc has no earnings call transcript available.